Literature DB >> 30410011

K-variant BCHE and pesticide exposure: Gene-environment interactions in a case-control study of Parkinson's disease in Egypt.

Thomas W Rösler1,2, Mohamed Salama3,4, Ali S Shalash5, Eman M Khedr6, Abdelhalim El-Tantawy7, Gharib Fawi8, Amal El-Motayam9, Ehab El-Seidy10, Mohamed El-Sherif7, Mohamed El-Gamal4, Mohamed Moharram4, Mohammad El-Kattan4, Muhammad Abdel-Naby4, Samia Ashour5, Ulrich Müller11, Astrid Dempfle12, Gregor Kuhlenbäumer13, Günter U Höglinger14,15,16.   

Abstract

Pesticide exposure is associated with increased risk of Parkinson's disease (PD). We investigated in Egypt whether common variants in genes involved in pesticide detoxification or transport might modify the risk of PD evoked by pesticide exposure. We recruited 416 PD patients and 445 controls. Information on environmental factors was collected by questionnaire-based structured interviews. Candidate single-nucleotide polymorphisms (SNPs) in 15 pesticide-related genes were genotyped. We analyzed the influence of environmental factors and SNPs as well as the interaction of pesticide exposure and SNPs on the risk of PD. The risk of PD was reduced by coffee consumption [OR = 0.63, 95% CI: 0.43-0.90, P = 0.013] and increased by pesticide exposure [OR = 7.09, 95% CI: 1.12-44.01, P = 0.036]. The SNP rs1126680 in the butyrylcholinesterase gene BCHE reduced the risk of PD irrespective of pesticide exposure [OR = 0.38, 95% CI: 0.20-0.70, P = 0.002]. The SNP rs1803274, defining K-variant BCHE, interacted significantly with pesticide exposure (P = 0.007) and increased the risk of PD only in pesticide-exposed individuals [OR = 2.49, 95% CI: 1.50-4.19, P = 0.0005]. The K-variant BCHE reduces serum activity of butyrylcholinesterase, a known bioscavenger for pesticides. Individuals with K-variant BCHE appear to have an increased risk for PD when exposed to pesticides.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30410011      PMCID: PMC6224461          DOI: 10.1038/s41598-018-35003-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


Introduction

Parkinson’s disease (PD) is a progressive neurodegenerative disease with intraneuronal aggregation of alpha-synuclein, and characteristic motor and non-motor symptoms, affecting more than 6.2 million people globally[1]. Monogenic inheritance only accounts for a small proportion of PD cases, whereas the etiology in more than 90% of the patients appears as complex interplay of multiple genetic and environmental risk factors[2]. Knowledge about causative factors is of utmost relevance to develop preventive measures and disease-modifying therapies. In the 1980s, 1-methyl-4-phenylpyridinium (MPP+) was discovered to induce neurodegeneration and parkinsonism in drug abusers[3]. MPP+ was marketed as pesticide under the tradename cyperquat[4] and showed structural similarities to other known pesticides, e.g. paraquat. This finding triggered intensive research about potential links between pesticides and PD. Three meta-analyses of epidemiological studies investigating the association of pesticides and PD have been carried out so far[5,6]. They consistently concluded that pesticide exposure and factors related to pesticide exposure (e.g. rural living, farming or well water drinking) are positively associated with the risk to develop PD[5,6]. Recent studies investigated whether risk conferred by pesticide exposure is modified by single nucleotide polymorphisms (SNPs) in candidate genes involved in detoxification or neuronal uptake of pesticides (e.g. aldehyde dehydrogenase 2 (ALDH2)[7], cytochrome P450 2 D6 (CYP2D6)[8], manganese-dependent superoxide dismutase (MnSOD)[9], nitric oxide synthase 1 (NOS1)[10], NAD(P)H dehydrogenase [quinone] 1 (NQO1)[9], multidrug resistance protein 1 (MDR1)[11], glutathione-S-transferase (GST)[12], paraoxonase 1 (PON1)[13], dopamine transporter (SLC6A3)[14]. Some studies found an interaction of pesticide exposure with genetic variants in ALDH2[7], CYP2D6[8], NOS1[10], PON1 concerning PD risk[13]. Most studies, however, did not find significant gene-environment interactions. A recent study searched genome-wide for genetic modifiers of PD risk conferred by pesticides in a relatively small number of patients, without finding any significant results[15]. In Egypt, pesticides are used extensively and under low safety standards, including types of pesticides that have been banned in Western countries for many years due to safety concerns[16]. Presently, around 40% of the Egyptian workforce is employed in agriculture with high likeliness of pesticide exposure[17]. Furthermore, Egypt has an age-adjusted prevalence (≥50 years) of 2,500-2,750 PD cases per 100,000 in distinct governorates[18,19], with a three-fold excess in rural over urban residence, which represents a massive increase by international comparison, particularly also compared to surrounding Arab countries[20]. Therefore, we collected a case-control sample in Egypt to study the association of PD with exposure to pesticides and their interaction with genetic variants involved in pesticide metabolism. Genes and variants of interest were selected by a detailed literature research on genes important for pesticide detoxification with a possible relation to neurodegeneration.

Results

Participants’ characteristics

The study sample consisted of n = 416 unrelated PD patients and n = 445 unrelated healthy controls of Egyptian ancestry (Table 1). The sex distribution did not differ between the groups, but PD patients were older than controls. Age at diagnosis, disease duration, and Hoehn and Yahr stage distribution for the PD patients are shown in Table 1.
Table 1

Participants’ characteristics.

CharacteristicPD cases (n = 416)Controls (n = 445)OR95% CIP-Value
Sex (male) [n (%)]253 (60.8)263 (59.1)1.074(0.82–1.41)0.608
Age (y) [mean (SD)]58.4 (8.8)48.6 (11.8)2.56*(2.18–3.02)<0.001*
Age at diagnosis (y) [mean (SD)]55.0 (8.8)n.a.
Disease duration (y) [mean (SD)]3.5 (2.8)n.a.
Hoehn & Yahr stage
   Stage 1 [n (%)]121 (29.1)n.a.
   Stage 1.5 [n (%)]111 (26.7)n.a.
   Stage 2 [n (%)]107 (25.7)n.a.
   Stage 2.5 [n (%)]20 (4.8)n.a.
   Stage 3 [n (%)]40 (9.6)n.a.
   Stage 4 [n (%)]14 (3.4)n.a.
   Stage 5 [n (%)]3 (0.7)n.a.
Head trauma [n (%)]10(2.4)19 (4.3)0.55(0.24–1.17)0.135
Rural living
   Most of life [n (%)]142 (34.1)135 (30.3)1.19(0.89–1.59)0.233
   Childhood [n (%)]138 (33.2)135 (30.3)1.14(0.86–1.52)0.372
Well water drinking [n (%)]27 (6.5)0 (0.0)n.a.n.a.<0.001
Illiteracy [n (%)]129 (31.0)100 (22.5)1.55(1.14–2.11)0.005
Coffee consumption [n (%)]66 (15.9)134 (30.1)0.44(0.31–0.61)<0.001
Black tea consumption [n (%)]391 (94.0)418 (93.9)1.01(0.58–1.77)0.972
Cigarette smoking [n (%)]69 (16.6)78 (17.5)0.94(0.65–1.33)0.714
Shisha smoking [n (%)]39 (9.4)31 (7.0)1.38(0.85–2.27)0.198
Pesticide exposure#163 (39.2)148 (33.2)1.29(0.98 1.71)0.071
Use of pesticides vs. non-exposed
   At home only [n (%)]44 (14.8)48 (13.9)1.08(0.69–1.68)0.745
   At work [n (%)]87 (25.6)69 (18.8)1.48(1.04–2.12)0.032
Pesticide classes used at home or/and at work vs. non-exposed
   Insecticides only [n (%)]82 (24.5)104 (25.9)0.93(0.66–1.29)0.926
   Herbicides and other [n (%)]46 (15.4)11 (3.6)4.91(2.58–9.94)<0.001

Odds ratio (OR), 95% confidence interval (CI) and P-value were calculated using logistic regression; *OR and CI calculated by logistic regression analysis for the ~10-year age difference between cases and controls. #Ever use of pesticides at home or at work, or >50% lifetime residence in rural areas. ‡Calculated using Fisher’s exact test because the logistic regression did not converge. The odds ratio for well water drinking could not be calculated because none of the controls drank well water. n.a., not applicable.

Participants’ characteristics. Odds ratio (OR), 95% confidence interval (CI) and P-value were calculated using logistic regression; *OR and CI calculated by logistic regression analysis for the ~10-year age difference between cases and controls. #Ever use of pesticides at home or at work, or >50% lifetime residence in rural areas. ‡Calculated using Fisher’s exact test because the logistic regression did not converge. The odds ratio for well water drinking could not be calculated because none of the controls drank well water. n.a., not applicable.

Environmental factors affect the risk of PD

In a first exploratory comparison, we analyzed differences in single environmental factors between PD patients and control individuals (Table 1). Coffee consumption was the only factor associated with a decreased risk of PD. Factors associated with increased risk of PD were age, well water drinking, illiteracy, use of pesticides at work, and specifically the use of herbicides at home and/or at work. The use of insecticides at home and/or at work showed a trend towards a positive association with PD. We then constructed a logistic regression model to assess the composite influence of environmental factors on the risk for PD. We considered all factors, which were significantly associated with PD in the single factor analysis (Table 1) for the model. Well water drinking was significantly associated with PD, but 25 out of 27 well water drinkers (93%) were also exposed to pesticides, leading to high collinearity (P < 0.001) between these factors, with pesticide exposure rather than well water drinking being the likely causal risk factor for PD[2,5]. Illiteracy was also highly collinear with pesticide exposure (P < 0.001), with 85% of the illiterate participants being pesticide exposed. Again, pesticide exposure rather than illiteracy was the biologically plausible risk factor[2,5]. Therefore, well water drinking and illiteracy were excluded from the logistic regression model. In our cohort, 79% of the coffee drinkers were not pesticide-exposed. Thus, coffee consumption was inversely correlated with pesticide exposure (P < 0.001). Nevertheless, we included coffee in the regression model because it is a well-known protective factor for PD[2,5]. Age was expectedly a highly significant risk factor for PD (P < 0.001). In addition, age interacted with pesticide exposure (P = 0.031) as explanatory variables for PD risk. Age was a somewhat stronger risk factor in the pesticide exposed subgroup (OR for 10 years age difference in the exposed subgroup: 2.95, 95% confidence interval: 2.39–3.71; in the unexposed subgroup: 2.56, 95% confidence interval: 1.18–3.02). Consequently, the final logistic regression model contained pesticide exposure, coffee consumption, age, and the interaction (age x pesticide exposure). In this analysis, age and pesticide exposure were confirmed as significant risk factors for PD, while coffee consumption was protective (Table 2).
Table 2

Environmental factors affecting the risk for PD.

VariableOR95% CIP-Value
Age2.86+(2.31–3.61)2 × 10−16
Coffee consumption0.63(0.43–0.90)0.013
Pesticide exposure*7.09(1.12–44.01)0.036

Statistical analysis was carried out by logistic regression (see results section for details of the model) using the model formula: affection status ~ pesticide exposure + coffee + age + (age ∗ pesticide exposure); +OR and CI calculated by logistic regression analysis for the ~10-year age difference between cases and controls. *Ever use of pesticides at home or at work, or >50% lifetime residence in rural areas.

Environmental factors affecting the risk for PD. Statistical analysis was carried out by logistic regression (see results section for details of the model) using the model formula: affection status ~ pesticide exposure + coffee + age + (age ∗ pesticide exposure); +OR and CI calculated by logistic regression analysis for the ~10-year age difference between cases and controls. *Ever use of pesticides at home or at work, or >50% lifetime residence in rural areas.

Influence of protective measures on PD risk

To identify factors modulating the risk for PD caused by occupational pesticide exposure, we compared protective measures in the subgroups of occupationally exposed participants, all of whom worked with pesticides in agriculture (n = 156 overall, n = 87 PD, n = 69 controls). Most of them had worked for more than 20 years with pesticides (90.8% of PD patients, 91.3% of controls). Their risk for PD was significantly reduced by wearing gloves during work and by washing hands after work, but not by changing clothes and taking a shower after work (Table 3).
Table 3

Influence of protective measures on the risk for PD.

Protective measurePD cases (n = 87)Controls (n = 69)OR95% CIP-Value
Wearing gloves during work
   Yes [n (%)]33 (37.9)44 (63.8)0.35(0.18–0.66)0.002
   No [n (%)]54 (62.1)25 (36.2)
Washing hands after work
   Yes [n (%)]67 (77.0)66 (95.7)0.15(0.03–0.47)0.003
   No [n (%)]20 (23.0)3 (4.3)
Changing clothes after work
   Yes [n (%)]17 (19.5)13 (18.8)1.05(0.47–2.37)0.912
   No [n (%)]70 (80.5)56 (81.2)
Shower after work
   Yes [n (%)]10 (11.5)15 (21.7)0.47(0.19–1.07)0.088
   No [n (%)]77 (88.5)54 (78.3)

Odds ratio (OR), 95% confidence interval (CI) and P- value were calculated using logistic regression.

Influence of protective measures on the risk for PD. Odds ratio (OR), 95% confidence interval (CI) and P- value were calculated using logistic regression.

Effect of variants in BCHE on PD risk

Next, we investigated the influence of genetic factors and gene-environment interactions on the risk to develop PD. After marker- and sample-wise quality control of the genotyping data, n = 372 PD patients and n = 394 control individuals remained, of whom n = 275 (n = 147 PD, n = 128 controls) had been exposed to pesticides. We expanded the logistic regression model described above by the SNP data and by an interaction term (SNP × pesticide exposure). We analyzed the dominant model for all SNPs (Supplementary Table S1). Only the SNP rs1126680 in the butyrylcholinesterase gene (BCHE) showed significant association with PD per se (Table 4; minor allele (G) frequency 0.140 in controls, 0.060 in PD; P = 0.007, OR = 0.38, 95% confidence interval: 0.20–0.70).
Table 4

Variants in BCHE affecting the risk for PD and their interaction with pesticide exposure.

SNPModelSNP main effectInteraction
OR95% CIP-ValueP-Value
Complete sample – pesticide exposed vs. non-exposed
   rs1126680dominant0.38(0.20–0.70)0.0020.795
   rs1803274dominant0.75(0.49–1.15)0.1870.007
Insecticide exposed subgroup vs. non-exposed
   rs1803274dominantn.a.n.a.n.a.0.002
Herbicide exposed subgroup vs. non-exposed
   rs1803274dominantn.a.n.a.n.a.0.893

Logistic regression analysis of SNP main effect and interaction with pesticides. The interaction P-value is derived from the interaction term between SNP and pesticide exposure. The logistic model contained SNP, pesticide exposure, age, coffee consumption and the interaction between pesticides and SNP as well as pesticides and age; affection status ~ SNP + pesticide exposure + coffee + age + (SNP ∗ pesticide exposure) + (age ∗ pesticide exposure); n.a. not applicable for subgroup analysis.

Variants in BCHE affecting the risk for PD and their interaction with pesticide exposure. Logistic regression analysis of SNP main effect and interaction with pesticides. The interaction P-value is derived from the interaction term between SNP and pesticide exposure. The logistic model contained SNP, pesticide exposure, age, coffee consumption and the interaction between pesticides and SNP as well as pesticides and age; affection status ~ SNP + pesticide exposure + coffee + age + (SNP ∗ pesticide exposure) + (age ∗ pesticide exposure); n.a. not applicable for subgroup analysis. SNP rs1803274 was not associated with PD per se (minor allele (A) frequency 0.241 in controls, 0.250 in PD), but interacted significantly with pesticide exposure (Table 4; interaction: P = 0.007 dominant). In carriers of the minor allele of rs1803274, pesticide exposure significantly increased the risk of PD (Fig. 1a; P = 0.0005, OR = 2.49, 95% confidence interval: 1.50–4.19) compared to unexposed individuals with the same genotype.
Figure 1

The SNP rs1803274 in BCHE increases the risk for PD in pesticide-exposed individuals. Effect of pesticide exposure on PD risk per genotype in the dominant model. The statistical measures are reported with reference to the same genotype (wt = wildtype/wildtype), (var = wildtype/variant or variant/variant) without pesticide exposure for which the odds-ratio is per definition 1. Odds-ratios are found in the upper right corner of the bars and 95% confidence intervals of the odds-ratios are indicated below and above the error bars. (a) Analysis of the whole sample comparing pesticide exposed to unexposed individuals. (b) Analysis of the subgroup of insecticide only exposed subgroup comparing insecticide exposed to unexposed individuals. (c) Analysis of the subgroup of herbicide and other pesticide exposed individuals comparing this group to unexposed individuals.

The SNP rs1803274 in BCHE increases the risk for PD in pesticide-exposed individuals. Effect of pesticide exposure on PD risk per genotype in the dominant model. The statistical measures are reported with reference to the same genotype (wt = wildtype/wildtype), (var = wildtype/variant or variant/variant) without pesticide exposure for which the odds-ratio is per definition 1. Odds-ratios are found in the upper right corner of the bars and 95% confidence intervals of the odds-ratios are indicated below and above the error bars. (a) Analysis of the whole sample comparing pesticide exposed to unexposed individuals. (b) Analysis of the subgroup of insecticide only exposed subgroup comparing insecticide exposed to unexposed individuals. (c) Analysis of the subgroup of herbicide and other pesticide exposed individuals comparing this group to unexposed individuals. In addition, we performed a subgroup analysis comparing non-exposed participants specifically to participants exposed only to insecticides or to herbicides, respectively. The interaction of rs1803274 was significant in the insecticide only exposed subgroup (Table 4; P interaction = 0.002), but not in the herbicide-exposed subgroup (Table 4; P interaction = 0.893). In carriers of the minor allele of rs1803274, insecticide exposure increased the risk of PD (Fig. 1b; P = 0.008, OR = 2.36, 95% confidence interval: 1.26–4.50) in comparison to the unexposed group with the same genotype. Herbicide exposure led to a strongly elevated PD risk independent of genotype (Fig. 1c).

Discussion

Studying 24 SNPs within 15 genes involved in pesticide detoxification and transport, we found one SNP (rs1803274 within BCHE) that is associated with increased risk for PD in pesticide-exposed Egyptians. BCHE codes for the protein butyrylcholinesterase (BChE) that is alternatively designated as pseudocholinesterase or plasma (choline) esterase. The minor allele of rs1803274 defines the K-variant (Kalow variant) of BCHE[21], which has been shown to reduce the activity of functional BChE in serum by 33%[22,23]. Similar to acetylcholinesterase (AChE), BChE hydrolyses choline esters, e.g. the neurotransmitter acetylcholine (ACh). BChE is 10-fold more common in the body than AChE, yet it does not have unique physiological functions that cannot be compensated by other enzymes. It does, however, play an important role as a bioscavenger protecting against organophosphate and carbamate toxicity[24]. These pesticides prevent degradation of ACh thus causing its accumulation and overstimulation of nerves and muscles with resulting toxic effects[25]. By binding to pesticides, BChE reduces the amount of active substances that can interfere with AChE to induce acute toxicity, or other esterases (e.g. neuropathy target esterase) to induce chronic neurotoxicity[26]. In our study, insecticides but not herbicides significantly increased PD risk in carriers of the K-variant of BCHE. Insecticides used in Egypt are mainly organophosphates (e.g. chlorpyriphos) and carbamates (e.g. carbofuran) that are insufficiently “bioscavenged” by the K-variant of BCHE presumably explaining the observed increased risk for PD. In contrast, herbicides are mainly pyrimidines (e.g. bispyribac) and organochlorines (e.g. acetochlor) that do not interact with BChE. One previous study reported an increased number of individuals with homozygosity for K-variant BCHE among PD patients compared to age-matched controls (P = 0.051)[27]. This finding, however, has not been confirmed so far[28]. In our sample, K-variant BCHE was also not associated with an increased risk for PD by itself, but it possibly facilitated pesticide-induced development of PD owing to the reduced activity and thus less effective bioscavenging property of the K-variant BCHE. Another SNP within BCHE, i.e. rs1126680, decreased PD risk in both, pesticide-exposed or unexposed individuals. This is not surprising since rs1126680 does not affect activity and function of BChE even in organophosphate pesticide exposed individuals[29]. Our findings on BChE, however, are not contradictory. In fact they highlight the different roles and functions of BChE under various conditions. On the one hand, BChE acts as a bioscavenger under pesticide-exposed conditions, backing AChE and protecting the brain against toxic effects[26]. However, it has recently been discovered that BChE has its own physiological role affecting brain homeostasis[30]. More important, recent studies proved that BChE might play certain roles in neurodegenerative diseases pathology[31]. However, the functional effects of BCHE rs1126680 in this context are unknown so far, but should be elucidated in future investigations. Since we did not actively match the PD and control groups for age, we assessed the influence of the factors pesticide exposure, coffee consumption, age, and age × pesticide interaction by logistic regression analysis. This approach confirmed pesticide exposure to increase the risk for PD (Table 2), which is consistent with previous observations in different populations[2,5]. Our estimate for pesticide exposure (OR = 7.09, 95% confidence interval: 1.12–44.01) is at the upper end of the range reported in prior studies (OR range: 1.5–7.0)[6] for pesticide exposure as risk factor of PD but the large confidence interval suggests a high degree of uncertainty concerning the exact value. Studying the efficacy of protective measures in participants working with pesticides in agriculture, we found that wearing gloves during work and washing hands after work reduced the risk for PD (Table 3). This is in line with a previous study showing that glove use and hygiene habits are able to reduce the risk of PD associated with certain pesticides[32]. Additionally, there is convincing evidence that the hands are the most contaminated anatomical region among people working with pesticides[33]. Also, it was shown that different pesticides are rapidly absorbed by the skin[34] emphasizing that glove use can protect from direct pesticide exposure and thus the risk to develop PD. Furthermore, we found the well-established protective effect of coffee against PD in the present study as well. In contrast to previous reports, however, we did not find a protective effect of tobacco smoking. This might be due to a possible pesticide contamination of tobacco products in Egypt[26]. We also identified a higher rate of illiteracy among PD patients as compared to controls. This is consistent with a previous door-to-door study in an Egyptian governorate that revealed a crude prevalence rate of PD of 1,103/100,000 among illiterates, as opposed to 557/100,000 in the general population[18]. Such correlation has not been found in other studies that were mainly conducted in highly industrialized nations. Given that illiteracy was collinear to pesticide exposure in our study, a high degree of illiteracy in pesticide-exposed peasants and less strict adherence to safety measures in this poorly educated group might partially explain the increased risk of illiteracy in Egyptian PD patients. Furthermore, the previously described increased risk for PD in people drinking well water was collinear with pesticide exposure. Therefore, illiteracy and well water drinking are most likely indicators for pesticide exposure in our sample. The present study confirms pesticide exposure as a risk factor and coffee consumption as a protective factor for PD in an Egyptian population. rs1126680 in BCHE decreased the risk for PD regardless of pesticide exposure, and rs1803274 in BCHE (K-variant) increased the risk for PD in individuals exposed to pesticides, particularly to insecticides, such as organophosphates and carbamates. This finding provides a basis to identify persons at risk for individualized preventive measures.

Methods

Ethics approval

The present study was approved by the ethics committee of Mansoura University, Egypt and the Technical University of Munich, Germany and conducted in accordance with the Declaration of Helsinki and all relevant guidelines and regulations. All study subjects provided written informed consent.

Study population

PD patients and controls without neurodegenerative disease were enrolled between January 2013 and December 2015 from the collaborating Neurology Departments of the Universities Mansoura, Ain Shams, Assiut, Sohag, Tanta and Zagazig. Participants underwent a standardized clinical assessment by consultant neurologists specialized in movement disorders. Patients with PD were diagnosed using the UK Brain Bank Criteria[35]. Patients with atypical, secondary or familial forms of Parkinsonism or other neurodegenerative diseases were excluded. The modified Hoehn & Yahr stage was ascertained in the on-medication state. Controls without neurodegenerative diseases, as ascertained by history and neurological examination, were recruited from attendants of the collaborating hospitals (healthy visitors or patients without neurodegenerative diseases).

Questionnaire data collection

Data about environmental factors assumed to modify the risk of PD was collected by trained study assistants in structured interviews using a standardized questionnaire. The questionnaire included the following sections: General information (sex, age, date of birth, ethnicity), disease history (year of diagnosis, disease duration, medication, family history), residence history (duration of rural or urban living), education (literacy, years of education), occupation history (occupation learnt, working history), nutrition habits (coffee, black tea), smoking habits (years and quantity of smoking, cigarette or shisha use), pesticides used at home or at work (duration, frequency, type of pesticides (insecticides, fungicides, herbicides), and pesticide handling (safety precautions, hygienic measures). Some items of the questionnaire were adapted from the risk factor questionnaires of the National Institute of Neurological Disorders and Stroke (NINDS, www.commondataelements.ninds.nih.gov/pd.aspx#tab=Data-Standards). Other factors were added to the questionnaire because of their prior epidemiological association with PD[2,5]. Participants were considered as pesticide-exposed if pesticides were ever used at home or at work or if they resided in a rural area for more than 50% of their lifetime.

Sample preparation and genotyping

Blood-cell-derived genomic DNA (80–100 ng/µL) was genotyped with the EP1 platform on 96.96 Dynamic Array and read by Fluidigm EP1 Genetic Analysis Scanner (Fluidigm Corporation, San Francisco, CA). Twenty-four Candidate SNPs were chosen in genes related to pesticide detoxification [CYP1B1 (rs1056836)[36], CYP2B6 (rs3745274)[37], CYP2C9 (rs1799853, rs1057910)[32], CYP2C18 (rs2296680)[38], CYP2E1 (rs2070676)[39], PON1 (rs662, rs854560, rs854572)[40], GSTO1 (rs11191972, rs4925)[41], GSTO2 (rs2297235, rs156697)[41], NAT1 (rs5030839, rs4987076)[42,43], NAT2 (rs15561)[43], NQO1 (rs1800566)[9], COMT (rs4680)[36], BCHE (rs1803274, rs1799807, rs1126680)[24,29,44], PLA2G6 (CM1211192)[45]] and pesticide transport [SLC6A3 (rs27072, rs2550956)[14,46]]. Assays include tagged, allele-specific PCR forward-primers and a common reverse primer. Genotypes were determined by using allele specific fluorescent probes (FAM and HEX), which were detected by the EP1 scanner. Data was analyzed by the Fluidigm SNP Genotyping Analysis Software to obtain genotype calls. Automatic calls that did not appear clear were either amended manually or uncalled. The overall call confidence was ≥98.5%.

Quality control of genetic data

Genetic data quality control was performed using PLINK 1.9 (www.cog-genomics.org/plink1.9/). First all samples were excluded in which >10% of genotypes were not reliably determined. Subsequently all markers that could not be genotyped in >10% of samples, markers with a minor allele frequency <1% and markers with a Hardy-Weinberg P-value < 0.0001 were removed. Quality control of genetic data led to a reduction in sample size from 861 in the analysis of demographic and environmental data to 766 samples included in the analysis of genetic data.

Statistical analysis

Statistical analyses were performed with the statistics software R version 3.3.3 (www.r-project.org). Numbers of study participants in Table 1 were obtained by tabulation. Numbers of study participants positive/negative for more than one variable as found in the results section were calculated by cross-tabulation. Most data were analyzed using logistic regression analyses with models specified in the results section. Logistic regression was performed in base R using the “glm” command, the family “binomial”, and the link function “logit”. Interaction of variables was analyzed by introducing interaction terms into the logistic regression analysis for the parameters indicated in the results section. P-values for interactions are if not stated otherwise the P-values of the interaction term. To estimate the P-value and odds-ratios for pesticide exposure in the rs1803274 wildtype (wt/wt) and variant carriers (wt/var and var/var) we stratified the sample according to these genotypes and performed a logistic regression for the independent variable pesticide exposure. For demographic and environmental variables, a P-value of <0.05 was considered significant. For genetic variables, a P-value of <0.01 was regarded as significant. A formal correction for multiple testing was not performed because all analyzed variants were candidate variants already described in the context of pesticide exposure by previous studies.
  46 in total

Review 1.  Organophosphate pesticide exposure and neurodegeneration.

Authors:  Fernando Sánchez-Santed; Maria Teresa Colomina; Elena Herrero Hernández
Journal:  Cortex       Date:  2015-10-20       Impact factor: 4.027

2.  MDR1 C3435T polymorphism and interaction with environmental factors in risk of Parkinson's disease: a case-control study in Japan.

Authors:  Chikako Kiyohara; Yoshihiro Miyake; Midori Koyanagi; Takahiro Fujimoto; Senji Shirasawa; Keiko Tanaka; Wakaba Fukushima; Satoshi Sasaki; Yoshio Tsuboi; Tatsuo Yamada; Tomoko Oeda; Hiroyuki Shimada; Nobutoshi Kawamura; Nobutaka Sakae; Hidenao Fukuyama; Yishio Hirota; Masaki Nagai
Journal:  Drug Metab Pharmacokinet       Date:  2012-09-11       Impact factor: 3.614

3.  Epidemiological study and clinical profile of Parkinson's disease in the Assiut Governorate, Egypt: a community-based study.

Authors:  Eman M Khedr; Ghada S Al Attar; Mahmoud R Kandil; Nageh F Kamel; Noha Abo Elfetoh; Mohamed A Ahmed
Journal:  Neuroepidemiology       Date:  2012-03-29       Impact factor: 3.282

Review 4.  Physiological roles for butyrylcholinesterase: A BChE-ghrelin axis.

Authors:  Stephen Brimijoin; Vicky Ping Chen; Yuan-Ping Pang; Liyi Geng; Yang Gao
Journal:  Chem Biol Interact       Date:  2016-02-23       Impact factor: 5.192

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

6.  Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves 18FDG retention in 5XFAD mouse model of Alzheimer's disease.

Authors:  Drew R DeBay; George A Reid; Ian R Macdonald; George Mawko; Steve Burrell; Earl Martin; Chris V Bowen; Sultan Darvesh
Journal:  Brain Res       Date:  2017-07-17       Impact factor: 3.252

7.  Determination of cyperquat (1-methyl-4-phenylpyridinium chloride) residues in soil by gas-liquid chromatography.

Authors:  S U Khan; K S Lee
Journal:  J Agric Food Chem       Date:  1976 May-Jun       Impact factor: 5.279

8.  Characterizing exposures and neurobehavioral performance in Egyptian adolescent pesticide applicators.

Authors:  Diane Schertler Rohlman; Ahmed A Ismail; Gaafar Abdel-Rasoul; Michael Lasarev; Olfat Hendy; James R Olson
Journal:  Metab Brain Dis       Date:  2014-05-16       Impact factor: 3.584

9.  Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease.

Authors:  Ya-Xing Gui; Zhong-Ping Xu; Hong-Mei Liu; Jin-Jia Zhao; Xing-Yue Hu
Journal:  Parkinsonism Relat Disord       Date:  2012-11-20       Impact factor: 4.891

10.  Phospholipase B activity and organophosphorus compound toxicity in cultured neural cells.

Authors:  David J Read; Lynda Langford; Helen R Barbour; Philip J Forshaw; Paul Glynn
Journal:  Toxicol Appl Pharmacol       Date:  2006-08-08       Impact factor: 4.219

View more
  5 in total

Review 1.  Neurotoxin-Induced Rodent Models of Parkinson's Disease: Benefits and Drawbacks.

Authors:  Mohamed El-Gamal; Mohamed Salama; Lyndsey E Collins-Praino; Irina Baetu; Ahmed M Fathalla; Amira M Soliman; Wael Mohamed; Ahmed A Moustafa
Journal:  Neurotox Res       Date:  2021-03-25       Impact factor: 3.911

2.  Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone-induced Parkinson's disease in rats.

Authors:  Sanaa Ahmed; Mahmoud M El-Sayed; Mohamed A Kandeil; Marwa M Khalaf
Journal:  Saudi Pharm J       Date:  2022-03-16       Impact factor: 4.562

3.  Differential transcript usage in the Parkinson's disease brain.

Authors:  Fiona Dick; Gonzalo S Nido; Guido Werner Alves; Ole-Bjørn Tysnes; Gry Hilde Nilsen; Christian Dölle; Charalampos Tzoulis
Journal:  PLoS Genet       Date:  2020-11-02       Impact factor: 5.917

4.  Single Nucleotide Polymorphisms Associated With Gut Homeostasis Influence Risk and Age-at-Onset of Parkinson's Disease.

Authors:  Anastazja M Gorecki; Megan C Bakeberg; Frances Theunissen; Jade E Kenna; Madison E Hoes; Abigail L Pfaff; P Anthony Akkari; Sarah A Dunlop; Sulev Kõks; Frank L Mastaglia; Ryan S Anderton
Journal:  Front Aging Neurosci       Date:  2020-11-17       Impact factor: 5.750

5.  Altered levels of variant cholinesterase transcripts contribute to the imbalanced cholinergic signaling in Alzheimer's and Parkinson's disease.

Authors:  Muslum Gok; Nimrod Madrer; Tamara Zorbaz; Estelle R Bennett; David Greenberg; David A Bennett; Hermona Soreq
Journal:  Front Mol Neurosci       Date:  2022-09-02       Impact factor: 6.261

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.